Quick Facts

Share SHARE

Scientific Games Corp (SGMS) said Friday it completed the merger with Bally Technologies Inc. The aggregate transaction value was about $5.1 billion, including the refinancing of nearly $1.8 billion of existing Bally net debt. "We are excited by the opportunities that will be created by combining...

Immunomedics, Inc., (IMMU) said Friday that the U.S. Food and Drug Administration has granted orphan drug status for the use of veltuzumab, the company's humanized anti-CD20 antibody, for the treatment of pemphigus. Pemphigus is a debilitating and potentially fatal autoimmune blistering disease of...

Mercer, a subsidiary of Marsh & McLennan Cos Inc (MMC), Friday agreed to buy SCM Strategic Capital Management AG, a Swiss-based specialist private markets advisor and delegated solutions provider. The financial terms of the deal were not disclosed. The acquisition will further strengthen Mercer's...

UK-based drugmaker AstraZeneca Plc (AZN.L, AZN) Friday announced plans to expand its biologics manufacturing center in Frederick, Maryland. The more than $200 million project will increase production capacity at the facility to support AstraZeneca's maturing pipeline, and will help position the company...

Bio Blast Pharma Ltd (ORPN) Friday reported third-quarter net loss of $2 million or $0.16 per share compared with a loss of $195 thousand or $0.02 per share last year. Analysts polled by Thomson Reuters estimated a loss of $0.09 per share for the quarter. Analysts' estimates typically exclude special...

Intrawest Resorts Holdings Inc (SNOW), a North American mountain resort and adventure company, Friday announced the hiring of Thomas Marano as the company's Chief Executive Officer, effective immediately. Marano replaces William Jensen who has tendered his resignation for personal reasons. Additionally,...

Tsakos Energy Navigation Ltd (TNP) Friday reported third-quarter net earnings of $3 million or $0.04 per share compared with a loss of $2.4 million or $0.04 per share last year. Total revenues for the quarter were $120.9 million compared with $107.6 million in the prior year. Revenues, net of voyage...

New York Mortgage Trust, Inc. (NYMT) said Friday that it has priced an underwritten public offering of 13 million shares of its common stock at a public offering price of $7.94 per share. NYMT also granted the underwriters an option to purchase up to an additional 1.95 million shares of common stock....

GE (GE) announced the appointment of four new Company officers namely, Harel Kodesh, Collin Parris, Sharis Pozen and Weiming Xiang. GE said it has 196 officers globally who lead large revenue-generating businesses or are in critical technology or functional roles, helping to drive growth. Commenting...

Apparel retailer Dillard's Inc. (DDS) announced that its board has approved a share repurchase program authorizing the Company to repurchase up to $500 million of its Class A Common Stock. The company also noted that its board declared a cash dividend of $0.06 per share on the Class A and Class B...

European car giant Volkswagen Group (VKW.L, VLKAF.PK, VOW.BE) reported investing 85.6 billion euros in new models, innovative technologies and its worldwide presence in its Automotive unit over the coming five years. Nearly two-thirds of the total investment amount would flow into increasingly efficient...

Dow Chemical Co. (DOW) and Third Point LLC (TPRE) announced a comprehensive agreement to add four new, independent directors to Dow's Board. Mark Loughridge, Ray Milchovich and R. "Steve" Miller will join the Board on January 1, 2015. Richard Davis will join in May 2015 following the 2015 Annual Meeting...

Harbinger Group Inc. (HRG) reported that its net loss attributable to common and participating preferred stockholders for the fourth quarter of fiscal 2014 was $6.3 million or $0.03 per share, narrower than $202.3 million or $1.45 per share in the year ago quarter. Consolidated Operating income was...

Cerus Corp. (CERS) said the U.S. Food and Drug Administration has accepted its clinical protocol to make the INTERCEPT Blood System for plasma, available under an Investigational Device Exemption or IDE, for treatment of convalescent plasma collected from Ebola disease survivors for passive immune therapy....

Abaxis, Inc. (ABAX), a medical products company manufacturing point-of-care instruments and consumables for the medical, research, and veterinary markets worldwide and providing reference lab services to the veterinary and research markets in the U.S., announced the closing of a stock purchase deal to...